Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome
- PMID: 26888055
- DOI: 10.1002/humu.22971
Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome
Abstract
Lynch syndrome is the most common familial cancer condition that mainly predisposes to tumors of the colon and endometrium. Cancer susceptibility is caused by the autosomal dominant inheritance of a loss-of-function mutation or epimutation in one of the DNA mismatch repair (MMR) genes. Cancer risk assessment is often possible with nonsynonymous coding region mutations, but in many cases patients present with DNA sequence changes within noncoding regions, including the promoters, of MMR genes. The pathogenic role of promoter variants, and hence clinical significance, is unclear and this hinders the clinical management of carriers. In this review, we provide an overview of the classification of MMR gene variants, outline the laboratory assays and online resources that can be used to assess the causality of promoter variants in Lynch syndrome, and highlight some of the practical challenges of demonstrating the pathogenicity of these variants. In conclusion, we propose a guide that could be integrated into the current InSiGHT classification scheme to help determine if a MMR gene promoter variant is pathogenic.
Keywords: 5′ UTR; Lynch syndrome; cancer susceptibility; noncoding variant; promoter.
© 2016 WILEY PERIODICALS, INC.
Similar articles
-
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.Oncol Rep. 2016 Nov;36(5):2823-2835. doi: 10.3892/or.2016.5060. Epub 2016 Sep 1. Oncol Rep. 2016. PMID: 27601186
-
Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.Cancer Med. 2019 Sep;8(12):5534-5543. doi: 10.1002/cam4.2432. Epub 2019 Aug 6. Cancer Med. 2019. PMID: 31386297 Free PMC article.
-
Update on Lynch syndrome genomics.Fam Cancer. 2016 Jul;15(3):385-93. doi: 10.1007/s10689-016-9882-8. Fam Cancer. 2016. PMID: 26873718 Free PMC article. Review.
-
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.J Natl Cancer Inst. 2007 Feb 21;99(4):291-9. doi: 10.1093/jnci/djk051. J Natl Cancer Inst. 2007. PMID: 17312306
-
Mismatch repair deficiency testing in clinical practice.Expert Rev Mol Diagn. 2016;16(5):591-604. doi: 10.1586/14737159.2016.1156533. Epub 2016 Mar 10. Expert Rev Mol Diagn. 2016. PMID: 26895074 Review.
Cited by
-
Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes.Front Genet. 2020 Aug 19;11:991. doi: 10.3389/fgene.2020.00991. eCollection 2020. Front Genet. 2020. PMID: 32973888 Free PMC article.
-
Lynch-like Syndrome: Potential Mechanisms and Management.Cancers (Basel). 2022 Feb 22;14(5):1115. doi: 10.3390/cancers14051115. Cancers (Basel). 2022. PMID: 35267422 Free PMC article. Review.
-
Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review.J Cancer Res Clin Oncol. 2023 Jan;149(1):25-46. doi: 10.1007/s00432-022-04397-0. Epub 2022 Oct 17. J Cancer Res Clin Oncol. 2023. PMID: 36251064 Free PMC article.
-
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers.Clin Epigenetics. 2023 Jun 3;15(1):95. doi: 10.1186/s13148-023-01511-y. Clin Epigenetics. 2023. PMID: 37270516 Free PMC article.
-
WRN Germline Mutation Is the Likely Inherited Etiology of Various Cancer Types in One Iranian Family.Front Oncol. 2021 Jun 7;11:648649. doi: 10.3389/fonc.2021.648649. eCollection 2021. Front Oncol. 2021. PMID: 34164337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources